Evaluates novel Transcranial Magnetic Stimulation (TMS)
methods for the treatment of post-traumatic stress disorder (PTSD) and
depressive symptoms to determine which strategies provide the greatest benefit to patients.
Transcranial Magnetic Stimulation (TMS) is a non-invasive
brain stimulation technique FDA-approved for the treatment of major depressive
disorder (MDD) and obsessive compulsive disorder (OCD). However, there is
growing evidence that a targeted strategy for delivering TMS treatment would
yield superior clinical outcomes if it were more tailored to individual
neuroanatomy. In this study, we plan to examine whether functional Magnetic Resonance Imaging (fMRI) guided TMS might yield an even greater leap forward in promoting optimal
The study provides TMS treatment at no cost to participants; no insurance is required. Participation includes 20 sessions of TMS treatment over the
course of 7 weeks, clinical interviews with study staff, one fMRI scan, and monthly follow-up phone calls for 6 months post-treatment.
Compensation for the fMRI visit is provided.
Study Identifier: 826007
Contact the research team to learn more about this study.